The protease-resistant infectious prion protein, PrP res , that causes transmissible spongiform encephalopathies, is remarkably resistant to conventional physical and chemical sterilization methods, including heat. It was hypothesized that thermal-dependent PrP res degradation has been underestimated, and the effect of prolonged incubation at 37uC, 55uC, and 80uC on PrP res detection was examined using brain homogenates from chronic wasting disease-affected elk and mule deer (PrP CWD ). Immunoblotting demonstrated progressive loss of PrP CWD immunoreactivity with time in all incubated samples as temperature increased, and PrP CWD was virtually undetectable after 90 days of incubation at 55uC and 80uC. These results indicate that decontamination methods and tissue disposal systems maintaining elevated temperatures for long periods of time could interfere with immunodetection, and the reliability of assays for PrP res detection could be compromised when applied to tissues exposed to heat with time. Although these results may suggest that such prolonged heat treatment could destroy prions, the observed loss of immunoreactivity does not necessarily correlate with a concurrent loss of infectivity. Bioassay is needed to determine if samples that have been incubated under these conditions retain infectivity.
A large proportion of samples evaluated by transmissible spongiform encephalopathy (TSE) surveillance programs are affected with some degree of postmortem or postcollection tissue decomposition. Given the economic and public health implications of misclassifying prion disease status, concern has arisen in regard to the reliability of TSE tests when applied to deteriorated tissue. Severely decomposed nervous tissue cannot be evaluated by immunohistochemistry (IHC) or histology since tissue architecture is lost. However, it has largely been concluded that autolysis does not compromise the accuracy of assays that detect the proteinase-resistant, pathogenic isoform of the prion protein (PrP res ). 2, 5, 7, 8, 12, 16 It was hypothesized that over a relatively long period of time, exposure to heat may have a more substantial effect on PrP res immunodection than previously considered. The objective of the present study was to characterize PrP CWD detectability with time in brain samples subjected to heat in vitro as determined by Western blot.
Brain from 2 elk and 1 mule deer testing positive for chronic wasting disease (CWD) by IHC were studied. The brain tissues were not collected from the animals aseptically; however, a sterile technique was used in the laboratory preparations to avoid introduction of additional microorganisms. Brain tissue from each animal was homogenized separately using a homogenizer a . Homogenates were incubated without dilution or at a concentration of 20% (weight/volume) in sterile protease-free water. Homogenates were incubated at 37uC, 55uC, or 80uC for 0-198 days. Samples of incubating brain were removed at various time points and stored at 270uC until tested for PrP CWD . Detection of PrP CWD was achieved by testing equal amounts (mg weight) of brain tissue with a commercially available Western blot (WB) for TSE diagnosis b . Samples were digested with proteinase K (PK) before immunoblotting (as directed by the manufacturer). Equal volumes (mg weight) of brain tissue were PK treated and tested so that results between samples incubated with or without dilution could be directly compared. Samples used for this study were strongly positive by IHC; unincubated samples produced banding patterns in the WB that obscured neighboring lanes and were above the linear detection limits of the densitometer. Therefore, after incubation and PK digestion, samples were diluted to more accurately produce treatment response correlations. Dilutions depended on prion load in each stock homogenate, as reflected by signal strength in WB. Specifically, samples originating from elk homogenates 1 or 2 were always diluted 1:2 or 1:4, respectively, before mixing with equal volumes of sample buffer for testing. Samples from the mule deer homogenate required no dilution before mixing with sample buffer. PrP CWD signal intensity was compared between samples using densitometric analysis of all 3 PrP CWD bands. c Results demonstrated a consistent loss of PrP CWD signal with time. When brain tissue was incubated at 37uC, 55uC, and 80uC, the rate of PrP CWD signal loss increased with temperature ( Figs. 1 and 2) . When CWD-affected brain tissues were incubated at 55uC as 20% suspensions in water, mean PrP CWD signal loss was 56% (62.5) by day 16, and PrP CWD was almost below detection after 98 days of incubation (mean signal loss of 94.2% 6 4.1). Chronic wasting disease-affected brain homogenates incubated without dilution at 55uC under the same conditions showed less signal reduction. However, after 198 days of incubation, the PrP CWD signal was at least 95% reduced in all samples, regardless of homogenate concentration during incubation ( Fig. 3 ).
There are a number of possible explanations for the timeand temperature-dependent reduction in PrP CWD immunoreactivity demonstrated in these studies. One possibility is that the effect is due to an increase in susceptibility to PK, which is used routinely in the WB method. However, this is not the case, since signals were similarly reduced in samples tested without PK treatment (data not shown). Dilution of samples with water enhanced the signal loss. The mechanism for this is unclear, but could involve hydrolysis or reduced PrP CWD structural stability. It is possible that incubated brain tissue could have been contaminated during necropsy tissue collection with microorganisms that may contribute to PrP CWD destruction. However, no microorganisms were isolated from samples of brain homogenates before and after 16 days of incubation at 55uC. Furthermore, because this phenomenon was ob-served with brain tissue from 3 different animals collected at various times, it is unlikely that similar microbiological conditions could have occurred in all 3 samples. It is possible that the reduction of immunoreactivity relates to the formation of aggregates that cannot enter the gel. Whereas high molecular weight smears that may indicate oligomeric PrP CWD aggregate formation are evident in many of the samples, especially those incubated for longer periods of time at 37uC, they are not present in samples that exhibit markedly reduced immunoreactivity. When monoclonal antibody-based immunoassays are used, immunodetection could be limited by partial PrP CWD degradation and selective epitope loss or cross-linking. Tissue examination using assays based on other monoclonal antibodies and other formats (e.g., enzyme-linked immunosorbent assays) and could reveal such selective epitope loss. Although modifications to PrP Res have the potential to diminish prion titer, 6 infectivity has been established with scrapie samples that produce no signal on WB. 13 Ultimately, in order to determine if temperature-and time-dependent reduction of PrP CWD immunodetection correlates with prion degradation and reduced infectivity, kinetic bioassay studies are required.
Prions are resistant to inactivation by several conventional physical or chemical sterilization treatments including heat, irradiation, detergents, acids and bases, alkylating agents, organic solvents, oxidizing agents, salts, and proteolytic enzymes. 3, 4, 9, 14 Since techniques that destroy prions (i.e., alkaline hydrolysis, treatment with the phenolic disinfectant LpH) may not be available or practical for disposal of infected animals or tissues, 3, 14, 15 alternative, practical methods for decontamination of TSEcontaminated biomaterial are needed. Because the reduction of PK-resistant PrP can be correlated to infectivity loss, 1, 8 we speculate that the time-and temperaturedependent reduction in PrP CWD immunoreactivity could reflect its destruction. Temperatures in the range of 55uC are similar to average temperatures occurring in decomposing or composting livestock carcasses. 10, 11 If the disappearance of PrP CWD immunoreactivity after exposure to elevated temperatures for extended periods of time correlates with infectivity loss, then it is possible that composting conditions might result in prion degradation. Furthermore, the results presented here raise a concern regarding the validity of PrP res immunoassays applied to decomposed tissues that have been subjected to high levels of heat for long periods of time. Investigation of the described effect using immunoassays that target different epitopes and bioassay are necessary to establish correlations between the loss of PrP CWD immunodetection and infectivity.
